Increased Liquefactive Necrosis Formation After Transarterial Chemoembolization Combined with Molecular Targeted Agents Plus Immune Checkpoint Inhibitors for Hepatocellular Carcinoma.
Yingliang WangChen ZhouJiacheng LiuQin ShiSongjiang HuangChongtu YangTongqiang LiYang ChenBin XiongPublished in: Cancer management and research (2021)
Patients with HCC who received TACE combined with MTGs plus ICIs have increased liquefactive necrosis formation, and the larger tumor size and higher alpha-fetoprotein level were associated with more liquefactive necrosis formation within the tumor.
Keyphrases